Luvesilocin clinical trials
How each study uses luvesilocin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the luvesilocin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- RE104 for Injection
- 4
Studies by the year they started
4 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Reunion Neuroscience Inc (4)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test luvesilocin.
- Apr 2027RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2 · Reunion Neuroscience Inc
- Jul 2027RE104 Safety and Efficacy Study in Generalized Anxiety DisorderPhase 2 · Reunion Neuroscience Inc
Studies
Open first, then newest update. How each study uses luvesilocin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesRecruitingPhase 2Reunion Neuroscience IncNCT07002034Written as RE104 for Injection
- RE104 Safety and Efficacy Study in Generalized Anxiety DisorderRecruitingPhase 2Reunion Neuroscience IncNCT07489651Written as RE104 for Injection
- RE104 Safety and Efficacy Study in Postpartum DepressionCompletedPhase 2Reunion Neuroscience IncNCT06342310Written as RE104 for Injection
- RE104 Clinical Lactation StudyCompletedPhase 1Reunion Neuroscience IncNCT06659263Written as RE104 for Injection
Codes
What other systems call luvesilocin · ClinicalTrials.gg INT016917
- UNII (FDA) J64JU3Z4Q2LUVESILOCINConfirmed FDA, Wikidata
- Wikidata Q118896392luvesilocinConfirmed FDA, Wikidata
- NCI Thesaurus C217735LuvesilocinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | J64JU3Z4Q2 | LUVESILOCIN | Confirmed FDA, Wikidata |
| Wikidata | Q118896392 | luvesilocin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C217735 | Luvesilocin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.